NIH-funded research R21 grant

Understanding ATP1A3-related illness using worm models to find new therapy targets

Official title: Identifying conserved cellular mechanisms involved in Alternating Hemiplegia of Childhood

Funded at Brown University · NIH-11373773 · Data updated 2026-11-12

Researchers are studying how faulty ATP1A3 genes cause Alternating Hemiplegia of Childhood and are using tiny worm models to find genes that could be targeted to treat the condition.

More Hemiplegia research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionBrown University
NIH-funded
Lab location1 site (Providence, United States)
Project startJune 1, 2026
Project endMay 31, 2028
Funding year2026
Award (this year)$408,585
NIH project number1R21NS142903-01A1
Project IDNIH-11373773 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with Alternating Hemiplegia of Childhood or related ATP1A3-associated conditions that may benefit from future targeted therapies.

Less likely to help

People not affected by ATP1A3-related diseases may not directly benefit from this basic discovery work.

What this research studies

This project uses C. elegans models that carry human ATP1A3 mutations to explore how these changes disrupt cellular function. The team will screen genes that can suppress disease-related defects and examine cellular processes relevant to AHC. By identifying proteins and pathways linked to the condition, they aim to point toward potential therapy targets that could help people with AHC in the future.

Why it matters

Potential benefit: If successful, the work could uncover new targets for therapies that help manage or treat AHC.

How similar studies have gone: Previous studies in model organisms have shown that modifying certain genes can influence disease-related cellular problems, suggesting potential for this approach.

Where this research is happening

  • Brown University
    Providence, United States
    Active

Researchers

  • Principal investigator: Hart, Anne Church — Brown University
  • Study coordinator: Hart, Anne Church

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.